Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.

Balata, H; Blandin Knight, S; Barber, P; Colligan, D; Crosbie, Emma J; Duerden, R; Elton, P; Evison, M; Greaves, M; Howells, J; Irion, K; Karunaratne, D; Kirwan, M; Macnab, A; Mellor, S; Miller, C; Newton, T; Novasio, J; Sawyer, R; Sharman, A; Slevin, K; Smith, E; Taylor, B; Taylor, S; Tonge, J; Walsham, A; Waplington, S; Whittaker, J; Booton, R; Crosbie, P

Affiliation

Manchester Thoracic Oncology Centre, North West Lung Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK

Issue Date

2018-10

Metadata

Show full item record

Abstract

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in populations eligible for lung cancer screening. The aim of this study was to determine whether a brief CV risk assessment, delivered as part of a targeted community-based lung cancer screening programme, was effective in identifying individuals at high risk who might benefit from primary prevention.

Citation

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease. 2018, 124: 148-153 Lung Cancer

Journal

Lung Cancer

URI

http://hdl.handle.net/10541/621298

DOI

10.1016/j.lungcan.2018.08.006

PubMed ID

30268454

Type

Article

Language

ISSN

1872-8332

Collections

All Christie Publications